ZENTALIS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.87 USD | -0.84% |
|
+5.32% | -21.65% |
| 29/05 | Zentalis Pharmaceuticals Announces Appointment of Luke Walker, M.D., to Board of Directors | CI |
| 24/05 | Zentalis Says Azenosertib Combo Shows 'Promise' in Relapsed Osteosarcoma Trial | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Bio Therapeutic Drugs | -0.84% | +5.32% | -21.65% | -54.42% | - | 84Cr |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- ZNTL Stock
- Charts Zentalis Pharmaceuticals, Inc.
- Comparison Chart
